Trial Information

Summary: RTOG 0418: A Phase II Study of Intensity Modulated Radiation Therapy (IMRT)to the Pelvis +/- Chemotherapy for Post-Operative Patients with Either Endometrial or Cervical Carcinoma

You have been asked to participate in this research study because you have endometrial or cervical cancer that has a high risk of recurring.  The purpose of this study is to test whether the use of an advanced radiation therapy delivery technique called intensity-modulated radiation therapy (IMRT) can spare your normal tissue, including small bowel and large bowel, from radiation.  Your quality of life will be studied to see if better sparing of healthy tissue can improve your quality of life after radiation.  This research is being done to try to reduce radiation side effects (especially diarrhea) that occur with the standard radiation methods.  With the new radiation techniques that are being used in this study (IMRT), special credentialing is required of all institutions prior to treating patients with IMRT.

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: October 6, 2008 at 2:42:06 PM